Vision Care Market Size is Expected to Reach USD 192.85 Billion by 2026, Exhibiting a CAGR of 5.6% | Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™ – Yahoo Finance

Is the fossil fuel recovery real, or a stepping stone to a fossil-free future? Register now for our 11/17 webinar at 2PM ET
Key Companies in Vision Care Market are Alcon (Part of Novartis AG), Essilor, CooperVision, Johnson & Johnson Services, Inc., Bausch Health Companies Inc., GrandVision, Carl Zeiss, Menicon, Luxottica, Other Prominent Players
Pune, India, Nov. 16, 2021 (GLOBE NEWSWIRE) — The global vision care market size is expected to reach USD 192.85 billion by 2026, exhibiting a CAGR of 5.6% during the forecast period. Increasing awareness regarding ocular diseases in emerging nations is expected to aid the growth of the market. The increasing adoption of vision care products will boost the vision care market growth in the forthcoming year.
In addition, the growing cases of cataracts to create growth opportunities for the market. For instance, according to the World Health Organization, 51% of the world’s blindness is caused due to cataracts. In addition, the increasing risks of cataract incidence predominantly in developing as well as developed countries will fuel demand for vision care.

Get Sample PDF Brochure:

As per the report, published by Fortune Business Insights in a report, titled “Vision Care Market Size, Share & Industry Analysis, By Product Type (Eyewear, Intraocular Lens, and Ocular Health), By Distribution Channel (Retail Store, Online Store, Hospital & Clinics), and Regional Forecast, 2019-2026” the market size stood at USD 125.16 billion in 2018. The report offers dynamic insights on all the prevailing trends and characteristics of the vision care market. It provides an all-encompassing summary and analytical data of all the segments.

Report Scope & Segmentation
Report Coverage
Forecast Period
2018 to 2026
Forecast Period 2021 to 2028 CAGR
2026 Value Projection
USD 192.85 Billion
Base Year
Market Size in 2018
USD 125.16 Billion
Historical Data for
2015 to 2017
No. of Pages
Segments covered
Product Types, Distribution Channel and Geography
Growth Drivers
Increasing Accessibility of Vision Care Products to Boost Market Growth
Increasing Cases of Cataract Will Aid the Growth of the Intraocular Lenses Segment during the Forecast Period
Spectacles Segment to Account for Maximum Share in the Forthcoming Years

For more information in the analysis of this report, visit:

FDA Approval for Pargon’s New Manufacturing Facility to Spur Sales Opportunities
The approval of Paragon Vision Science’s newly-constructed contact lens manufacturing site in suburban Phoenix by the U.S. Food and Drug Administration (FDA) will boost the vision care market trends. For instance, The facility will produce advanced ortho-k products such as Paragon CRT® for use in the United States. The new site is more than double the size of the company’s current plant in nearby Mesa, Arizona.
Furthermore, the launch of TECNIS Synergy IOL by Johnson and Johnson’s vision division will foster the growth of the market. For instance, Johnson and Johnson’s vision division launched TECNIS Synergy IOL, an advanced intraocular lens that provides continuous high-contrast vision correction for patients with cataracts from far through near, even in low-light conditions. In addition, the increasing accessibility of spectacles and sunglasses owing to the affordability in emerging nations will further accelerate the growth of the market

Quick Buy – Vision Care Market Research Report:

Favorable Reimburusmnet policies to Stimulate Growth in North America
North America generated a revenue of USD 38.82 billion in 2018 and is expected to remain dominant during the forecast period. Higher adoption of vision care products in the region will further create opportunities for the market. Factors such as increasing awareness of the ocular disease, favorable reimbursement for cataract surgery, and increasing inclination towards eye care products is projected to further escalate the market’s revenue in North America. The market in Latin America is estimated to grow at a steady rate alongside the Middle East and Africa. The unmet need for vision care in Latin America is estimated to be one of the prime reasons for spurring the growth in the region
Increasing Cases of Cataract to Promote Healthy Growth
The increasing incidence of cataracts around the world will subsequently aid the growth of the market in the forthcoming period. According to the Global Burden of Diseases Study, 2010 cataract caused worldwide 33.4% of all blindness in 2010 and around 10.8 million people were blind and 35.1 million were visually impaired due to cataract. With the growing risk of cataracts, the demand for vision is increasing, which therefore supports market growth. The growing population of individuals suffering from ocular diseases is expected to be one of the key reasons for driving the market.

Some of the Major Companies in the Global Vision Care Market:
Alcon (Part of Novartis AG)
Johnson & Johnson Services, Inc.
Bausch Health Companies Inc.
Carl Zeiss
Other Prominent Players

Have Any Query? Ask Our Experts:

Table of Content from Vision Care Market:
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Introduction of New Products / Approvals (by Major Players)
Epidemiology of Ocular Disease – For Key Countries, 2018
Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2018
Snapshot: U.S Reading Glasses Market, 2018
Key Trends in Vision Care Market
Key Pipeline Products
Global Vision Care Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Product Type
Contact Lens
Intraocular Lenses
Ocular Health
Market Analysis, Insights and Forecast – By Distribution Channel
Retail Store
Online Store
Hospitals and Clinics
Market Analysis, Insights and Forecast – By Region
North America
Asia Pacific
Latin America
Middle East & Africa
North America Vision Care Market Analysis, Insights and Forecast, 2015-2026
TOC Continued….

Ask for Customization of this Report:

About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]

An analyst slashes his price target on the EV battery stock the same day the company hits a milestone.
Sorrento Therapeutics (SRNE) has plans to shortly advance its Bruton’s tyrosine kinase (Btk) inhibitor abivertinib into pivotal testing for the treatment of hospitalized COVID-19-infected patients, yet abivertinib has recently been making waves as a possible therapy for an entirely different disease. Last week, the peer-reviewed journal Clinical Cancer Research published the results from a pivotal study based in China in which abivertinib was tested on 227 heavily pretreated NSCLC (non-small cel
Shares of electric vehicle start-up Canoo Holdings (NASDAQ: GOEV) were moving higher on Tuesday, after the company reported third-quarter earnings and said it will begin production of its first vehicle sooner than expected. As of 3 p.m. EST, Canoo's shares were up about 18.3% from Monday's closing price. Canoo reported its third-quarter results after the U.S. markets closed on Monday, and they were better than expected.
Singapore-based e-commerce, payments, and online-gaming company Sea Limited (NYSE: SE) dropped 3.5% through 2:45 p.m. EST Tuesday afternoon after reporting mixed results for its fiscal Q3 2021. Analysts had forecast Sea would lose $0.65 per share on less than $2.5 billion in sales for the quarter. As it turned out, Sea booked sales of $2.7 billion — but lost $0.84 per share in the process.
The company delivered quarterly results ahead of expectations, but investors are focusing on a couple of potential problems.
Yahoo Finance's Ines Ferre joins the Live show to review investors' interest driving the latest EV sector surge.
In cruise news today, shares of Royal Caribbean (NYSE: RCL), Carnival (NYSE: CCL), and Norwegian Cruise Line Holdings (NYSE: NCLH) are all down, falling 2.1%, 3.8%, and 7.6%, respectively, as of 11:30 a.m. EST. It said that although it's not quite profitable yet, with 40% of its capacity operating again by the end of the quarter and 57.4% occupancy rates, it's on track to reach a "crucial inflection point" in the first quarter 2022 with operating cash flow turning positive.
Shares of African e-commerce company Jumia Technologies (NYSE: JMIA) were having a bad day on Tuesday after the company released financial results for the third quarter of 2021. For Q3, Jumia reported revenue of $42.7 million, which was up 8.5% year over year. For starters, gross merchandise volume (GMV), the amount of money flowing through Jumia's platform, was up both from last year and last quarter.
(Bloomberg) — OPEC said the global oil market will switch from being under- to over-supplied as early as next month as the economic rebound from the coronavirus pandemic falters.Most Read from BloombergAmazon Sued Over Crashes by Drivers Rushing to Make DeliveriesWhat Designers of Video Game Cities Understand About Real CitiesBiden Plan Funds New Bridges That Locals May Not WantHong Kong's New Museum Tries to Please Art World — and BeijingChronically Underfunded HBCUs Eye Scholarships in Biden
Nvidia GPUs power self-driving cars and cloud gaming, with the chip giant also expanding fast into the metaverse. Is Nvidia stock a buy?
With just seven weeks left in 2021, Wall Street’s big names are firming up their year-end forecasts. Mike Wilson, chief U.S. equity strategist at Morgan Stanley, has set a 4,400 target for the S&P 500 by the end of 2022. That implies a fall of 6% from current levels. In his forecast, Wilson points out the factors that are likely to weigh on the markets, including “uncertainty around that expectation goes up materially given cost pressures, supply issues, along with tax and policy uncertainty tha
Following a lengthy struggle to avoid delisting by the Nasdaq Stock Market because its shares trade under $1, swimwear and lingerie company Naked Brand Group (Nasdaq: NAKD) saw its shares skyrocket 43% in after-hours trading on Nov. 8. The catalyst was an announced merger with privately held electric vehicle (EV) company Cenntro Automotive Group. At this point it's unclear if Naked will effectively cease to exist or will continue making lingerie, but it will cease operating under its own name, taking Cenntro public in the process, almost as if it were a special purpose acquisition company (SPAC).
NEW YORK (Reuters) -JPMorgan Chase & Co has sued Tesla Inc for $162.2 million, accusing Elon Musk's electric car company of "flagrantly" breaching a contract the two corporate giants agreed in 2014 relating to warrants Tesla sold to the bank. The suit, filed in a Manhattan federal court, centers on a dispute over how JPMorgan re-priced its Tesla warrants as a result of Musk's notorious 2018 tweet that he was considering taking the carmaker private. It is unusual for a major Wall Street bank to sue such a high-profile client, although JPMorgan has done relatively little business with the electric carmaker over the past seven years, according to Tesla's filings and Refinitiv data.
Cinedigm (NASDAQ: CIDM) reported second-quarter results on Tuesday morning. The content producer and media-streaming services operator traded 26.9% lower by 2:35 p.m. EST, essentially erasing the gains of the last three months. Cinedigm's second-quarter sales rose 41% year over year to $10.1 million.
Peloton sells shares for the first time since its 2019 IPO. Yahoo Finance's Emily McCormick reports on how the stock is reacting.
Trust the stock markets to react the way you least expect. How else can investors in Blink Charging (NASDAQ: BLNK) explain the sharp drop in the electric vehicle (EV) charging stock the day the company appoints an executive to help expand its business? Blink Charging shares were down 8.6% as of 1:45 p.m. EST Tuesday but had dropped nearly 11.7% earlier in the day.
What happened Shares of Butterfly Network (NYSE: BFLY) climbed more than 14.8% on Tuesday. The digital health company closed at $7.52 a share on Monday, opened at $7.70 on Tuesday, and hit a high of $8.
Strategists at Morgan Stanley say investors should resist buying U.S. stocks as part of their 2022 preview, in which they argue that the "hotter, faster" cycle advances.
Employees at Activision Blizzard are calling for the resignation of CEO Bobby Kotick following new revelations into the role he may have played in creating the toxic workplace culture that has mired the company in controversy.
Shares of mobile chip leader Qualcomm (NASDAQ: QCOM) soared nearly 8% higher today, building on the company's gains since reporting on the final quarter of its 2021 fiscal year (the 12 months ended Sept. 26, 2021). The latest jump comes following Qualcomm's investor day presentation. Qualcomm's relationship with Apple (NASDAQ: AAPL) has been tenuous in recent years, and indications are that Apple might eventually part ways with Qualcomm.